Oral Session 3-9B MM: BM microenvironment

[OS3-9B-6] Structural modification and anti-myeloma activities of natural product, komaroviquinone

Mikio Okayama^1,2, Shotaro Kitabatake¹, Mariko Sato¹, Kota Fujimori¹, Koichi Samata¹, Daiju Ichikawa¹, Maiko Matsushita¹, Yutaka Suto³, Genji Iwasaki³, Taketo Yamada⁴, Fumiyuki Kiuchi⁵, Shinichiro Okamoto², Yutaka Hattori¹ (1.Clin. Physiol.and Therapeutics, Keio Univ. Faculty of Pharmacy, Tokyo, Japan, 2.Division of Hematol., Keio University School of Med., Tokyo, Japan, 3.Takasaki Health and Welfare University, Faculty of Pharmacy, Takasaki, Japan, 4.Department of Pathology, Saitama Medical University, Saitama, Japan, 5.Nature Medicines, Keio Univ. Faculty of Pharmacy, Tokyo, Japan)